Stock Earnings

Question 1

What are Tempest Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Tempest Therapeutics Inc has a total asset of $41, Net loss of $-41

Question 2

What are the key financial ratios for TPST?

Accepted Answer

Tempest Therapeutics Inc's Current ratio is 1.86, has a Net margin is 0, sales per share of $0.

Question 3

How is Tempest Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Tempest Therapeutics Inc data is not available.

Question 4

Is Tempest Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Tempest Therapeutics Inc has a net loss of $-41

Question 5

Does Tempest Therapeutics Inc have any liabilities?

Accepted Answer

yes, Tempest Therapeutics Inc has liability of 22

Question 6

How many outstanding shares for Tempest Therapeutics Inc?

Accepted Answer

Tempest Therapeutics Inc has a total outstanding shares of 3.38

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	13	13	11	12	9	15
Research & Development	22	28	17	22	17	20
Operating Expenses	36	42	29	34	26	35
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-36	-41	-29	-35	-28	-36
Income Tax Expense	0	0	0	0	--	--
Net Income	-36	-41	-29	-35	-28	-36
Net Income Growth	3%	41%	-17%	25%	-22%	-18%
Shares Outstanding (Diluted)	4.44	2.14	1.18	0.88	0.29	0.09
Shares Change (YoY)	124%	81%	33%	204.99%	200.99%	38%
EPS (Diluted)	-8.12	-19.49	-24.86	-40.19	-97.06	-376.4
EPS Growth	-55%	-22%	-38%	-59%	-74%	-41%
Free Cash Flow	-33	-33	-27	-31	-26	-30
Free Cash Flow Per Share	-7.43	-15.37	-22.76	-34.89	-89.19	-310.23
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-36	-42	-29	-34	-26	-35
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-36	-42	-29	-34	-26	-35
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	--

Tempest Therapeutics Inc (TPST) Price